EOSINOPHILS, EICOSANOID BIOSYNTHESIS AND METABOLISM

嗜酸性粒细胞、类二十烷酸生物合成和代谢

基本信息

  • 批准号:
    6612400
  • 负责人:
  • 金额:
    $ 24.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2003-06-30
  • 项目状态:
    已结题

项目摘要

The pathogenesis of airways reactivity in asthma is thought to involve a complex interaction between multiple cells stimulated by a diverse array of mediators from cytokines to lipids derived from arachidonic acid. The infiltration of eosinophils into the asthmatic lung has been through to play a central role in the etiology in the etiology of allergic asthma and eosinophils and eosinophils have a diverse capacity for eicosanoid biosynthesis as well as being cells which respond to lipid mediators. The metabolism of arachidonic acid by the 5-lipoxygenase (5-LO) pathway leads to the formation of several different biologically active metabolites including leukotrienes C4 and B4 which are thought to play important roles in terms of mediating allergic reactions. In addition, 5-LO also leads to the formation of 5-oxo-eicosatetraenoic acid (5-oxo-ETE) which has not been extensively studied, but recently recognized as a potent chomatactic factor for the human eosinophil. Fundamental questions remain concerning a complete description of the biosynthesis and metabolism of 5-oxo-ETE and related eicosanoids, in particular a complete description of the biosynthesis and metabolism of 5-oxo-ETE and related eicosanoids, in particular in cells which respond to this arachidonate metabolite including the eosinophil and macrophage. Recent investigations have led to the discovery of an additional 5-oxo glutathione adduct at carbon-7 (FOG7) which is also chemotactic for eosinophils and neutrophils. Transcellular biosynthesis also plays a major role in the production of biologically active eicosanoids through cell-cell biochemical cooperation. Little is known about the formation of 5-oxo-ETE eicosanoids in vivo, in particular within cells resident. Since the eosinophil is abundant in the asthmatic airways, a major focus of this proposal will involve detail investigations of the production of 5-oxo- eicosanoids and FOG7 in both animal and human models. The biochemical pathways or synthesis and metabolism of this class or eicosanoid will also be investigated. Highly sensitive mass spectrometric techniques will be employed to carry out these basic biosynthetic and metabolism studies as well as characterization and identification of enzymes involved in the biosynthetic and metabolic events.
哮喘气道反应性的发病机制被认为涉及多种细胞之间复杂的相互作用,这些细胞受到从细胞因子到花生四烯酸衍生的脂质等多种介质的刺激。嗜酸性粒细胞向哮喘肺部的浸润在过敏性哮喘的病因学中发挥着核心作用,并且嗜酸性粒细胞和嗜酸性粒细胞具有多种类二十烷酸生物合成能力,并且是对脂质介质作出反应的细胞。花生四烯酸通过 5-脂氧合酶 (5-LO) 途径的代谢导致形成几种不同的生物活性代谢物,包括白三烯 C4 和 B4,它们被认为在介导过敏反应方面发挥着重要作用。此外,5-LO还导致5-氧代-二十碳四烯酸(5-氧代-ETE)的形成,该酸尚未被广泛研究,但最近被认为是人类嗜酸性粒细胞的有效趋化因子。 关于5-氧代-ETE和相关类二十烷酸的生物合成和代谢的完整描述仍然存在基本问题,特别是5-氧代-ETE和相关类二十烷酸的生物合成和代谢的完整描述,特别是在响应这种花生四烯酸代谢物的细胞中,包括嗜酸性粒细胞和巨噬细胞。最近的研究发现了一种额外的 7 碳 5-氧代谷胱甘肽加合物 (FOG7),它对嗜酸性粒细胞和中性粒细胞也具有趋化作用。跨细胞生物合成在通过细胞与细胞生化合作生产具有生物活性的类二十烷酸方面也发挥着重要作用。对于体内 5-oxo-ETE 类二十烷酸的形成知之甚少,特别是在驻留细胞内。由于哮喘气道中嗜酸性粒细胞丰富,因此该提案的一个主要重点将涉及在动物和人类模型中详细研究 5-氧代二十烷酸和 FOG7 的产生。还将研究此类或类二十烷酸的生化途径或合成和代谢。将采用高度灵敏的质谱技术来进行这些基本的生物合成和代谢研究以及参与生物合成和代谢事件的酶的表征和鉴定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT Carl MURPHY其他文献

ROBERT Carl MURPHY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT Carl MURPHY', 18)}}的其他基金

High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry
通过 MALDI/离子淌度质谱法进行高通量脂质组学分析
  • 批准号:
    8687651
  • 财政年份:
    2012
  • 资助金额:
    $ 24.21万
  • 项目类别:
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry
通过 MALDI/离子淌度质谱法进行高通量脂质组学分析
  • 批准号:
    8545850
  • 财政年份:
    2012
  • 资助金额:
    $ 24.21万
  • 项目类别:
High Throughput Lipidomics Analysis by MALDI/Ion Mobility Mass Spectrometry
通过 MALDI/离子淌度质谱法进行高通量脂质组学分析
  • 批准号:
    8415669
  • 财政年份:
    2012
  • 资助金额:
    $ 24.21万
  • 项目类别:
Lipid Tandem Quadrupole Mass Spectrometer
脂质串联四极杆质谱仪
  • 批准号:
    7790416
  • 财政年份:
    2010
  • 资助金额:
    $ 24.21万
  • 项目类别:
Bioactive lipid mediators and reactive oxygen species
生物活性脂质介质和活性氧
  • 批准号:
    7142874
  • 财政年份:
    2005
  • 资助金额:
    $ 24.21万
  • 项目类别:
CORE E: Novel Detection Technique Development
核心E:新型检测技术开发
  • 批准号:
    6803753
  • 财政年份:
    2003
  • 资助金额:
    $ 24.21万
  • 项目类别:
BRIDGE C--LC/Mass Spectrometric Analysis/Neutral Lipids
BRIDGE C--LC/质谱分析/中性脂质
  • 批准号:
    6802648
  • 财政年份:
    2003
  • 资助金额:
    $ 24.21万
  • 项目类别:
Isoeicosanoids& Biologically Active Oxidized Phospholipi
异二十烷酸
  • 批准号:
    6611191
  • 财政年份:
    2002
  • 资助金额:
    $ 24.21万
  • 项目类别:
EOSINOPHIL, EICOSANOID, BIOSYNTHESIS AND METABOLISM
嗜酸性粒细胞、类二十烷酸、生物合成和代谢
  • 批准号:
    6263126
  • 财政年份:
    2001
  • 资助金额:
    $ 24.21万
  • 项目类别:
Isoeicosanoids& Biologically Active Oxidized Phospholipi
异二十烷酸
  • 批准号:
    6496039
  • 财政年份:
    2001
  • 资助金额:
    $ 24.21万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 24.21万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
  • 批准号:
    10723233
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 24.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了